Improved Inhibitors of Trypanothione Reductase by Combination of Motifs: Synthesis, Inhibitory Potency, Binding Mode, and Antiprotozoal Activities
暂无分享,去创建一个
F. Diederich | R. Krauth-Siegel | R. Brun | M. Kaiser | Daniel Fankhauser | Birgit S Lauber | Christian Eberle | B. S. Lauber | R. Luise Krauth‐Siegel
[1] J. Coura,et al. Chagas disease: a new worldwide challenge , 2010, Nature.
[2] A. Fairlamb,et al. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi☆ , 2010, Molecular and biochemical parasitology.
[3] F. Diederich,et al. Synthesis, Inhibition Potency, Binding Mode, and Antiprotozoal Activities of Fluorescent Inhibitors of Trypanothione Reductase Based on Mepacrine‐Conjugated Diaryl Sulfide Scaffolds , 2009, ChemMedChem.
[4] I. Gilbert,et al. Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase , 2009, ChemMedChem.
[5] Carlos A. Montanari,et al. Docking and molecular dynamics simulation of quinone compounds with trypanocidal activity , 2009, Journal of molecular modeling.
[6] F. Diederich,et al. Pentafluorosulfanyl as a Novel Building Block for Enzyme Inhibitors: Trypanothione Reductase Inhibition and Antiprotozoal Activities of Diarylamines , 2009, Chembiochem : a European journal of chemical biology.
[7] F. Diederich,et al. Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities. , 2008, Organic & biomolecular chemistry.
[8] Simon Croft,et al. Kinetoplastids: related protozoan pathogens, different diseases. , 2008, The Journal of clinical investigation.
[9] A. Zhang,et al. Regioselective Synthesis of 1-(2,6-Dichloro-4-Trifluoromethyl-phenyl)-4-Alkyl-1H-[1,2,3]-Triazoles , 2008, Molecules.
[10] Chang H. Park,et al. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines. , 2008, Bioorganic & medicinal chemistry.
[11] I. Gilbert,et al. Target assessment for antiparasitic drug discovery. , 2007, Trends in parasitology.
[12] W. Hunter. Picking pockets to fuel antimicrobial drug discovery. , 2007, Biochemical Society transactions.
[13] R. Gust,et al. Structure-activity relationship study to understand the estrogen receptor-dependent gene activation of aryl- and alkyl-substituted 1H-imidazoles. , 2007, Journal of medicinal chemistry.
[14] A. Fairlamb,et al. Drug Resistance in Leishmaniasis , 2006, Clinical Microbiology Reviews.
[15] V. Yardley,et al. Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide. , 2005, Journal of medicinal chemistry.
[16] R. L. Krauth-Siegel,et al. Dithiolproteine als Hüter des intrazellulären Redoxmilieus bei Parasiten: alte und neue Wirkstoff‐Targets bei Trypanosomiasis und Malaria , 2005 .
[17] R. Schirmer,et al. Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. , 2005, Angewandte Chemie.
[18] A. Fairlamb,et al. Two Interacting Binding Sites for Quinacrine Derivatives in the Active Site of Trypanothione Reductase , 2004, Journal of Biological Chemistry.
[19] A. Fairlamb. Chemotherapy of human African trypanosomiasis: current and future prospects. , 2003, Trends in parasitology.
[20] R. Krauth-Siegel,et al. Parasite-specific trypanothione reductase as a drug target molecule , 2003, Parasitology Research.
[21] A. Fairlamb,et al. Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase. , 2003, The Biochemical journal.
[22] M. Barrett,et al. Chemotherapy of human African trypanosomiasis. , 2002, Current pharmaceutical design.
[23] D. Marks,et al. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines , 2000 .
[24] F. Diederich,et al. Tetrakis(phenylamidinium)-Substituted Resorcin[4]arene Receptors for the Complexation of Dicarboxylates and Phosphates in Protic Solvents , 2000 .
[25] M. Barrett. The fall and rise of sleeping sickness , 1999, The Lancet.
[26] M. Berriman,et al. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. , 1999, Structure.
[27] A. Fairlamb,et al. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. , 1998, Journal of medicinal chemistry.
[28] E. Davioud‐Charvet,et al. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase. , 1997, Bioorganic & medicinal chemistry.
[29] S. J. Simpson,et al. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity. , 1997, Biochemistry.
[30] P. Karplus,et al. Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors. , 1996, Bioorganic & medicinal chemistry.
[31] W. Kabsch,et al. Crystal structure of the Trypanosoma cruzi trypanothione reductase·mepacrine complex , 1996, Proteins.
[32] C. Sergheraert,et al. 2-Amino diphenylsulfides as new inhibitors of trypanothione reductase. , 1995, International journal of antimicrobial agents.
[33] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[34] B. de Costa,et al. Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites. , 1993, Journal of Medicinal Chemistry.
[35] A. Fairlamb,et al. Metabolism and functions of trypanothione in the Kinetoplastida. , 1992, Annual review of microbiology.
[36] A. Fairlamb,et al. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. , 1992, The Biochemical journal.
[37] C. George,et al. Synthesis of isothiocyanato-1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidines, potential irreversible ligands at the dopamine re-uptake site , 1992 .
[38] Jockers-Scherübl Mc,et al. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. , 1989 .